What is the L-Arginine L-aspartate?

L-Arginine L-aspartate is , while it's Molecular Formula is C6H14N4O2 . C4H7NO4. L-Arginine L-Aspartate is used in investigation of the metabolic profiles of human breast cancer.

What is the CAS number for L-Arginine L-aspartate?

The CAS number of L-Arginine L-aspartate is 7675-83-4.

What is the L-Arginine L-aspartate?

L-Arginine L-aspartate is , while it's Molecular Formula is C6H14N4O2 . C4H7NO4. L-Arginine L-Aspartate is used in investigation of the metabolic profiles of human breast cancer.

What is the CAS number for L-Arginine L-aspartate?

The CAS number of L-Arginine L-aspartate is 7675-83-4.

Health Care Raw Materials Food Additive L-Arginine-L-aspartate 7675-83-4

Product Details

Quick Details

CasNo： 7675-83-4
Molecular Formula： C₆H₁₄N₄O₂^.C₄H₇NO₄
Purity： 99%

Health Care Raw Materials Food Additive L-Arginine-L-aspartate 7675-83-4

Molecular Formula:C6H14N4O2^.C4H7NO4
Molecular Weight:307.307
Vapor Pressure:7.7E-08mmHg at 25°C
Melting Point:220-221 °C
Boiling Point:409.1 °C at 760 mmHg
Flash Point:201.2 °C
PSA：225.84000
LogP:0.12610

L-Arginine L-aspartate(Cas 7675-83-4) Usage

Chemical Properties	White or almost white granules or powder.
Originator	Arginine aspartate,Microbase Biotech Co., Ltd.
Uses	Amino acid; nutrient. L-arginine-L-aspartate is widely used by athletes for its potentially ergogenic properties.
Therapeutic Function	Tonic, Stimulant, Hepatoprotectant
Biochem/physiol Actions	Substrate of nitric oxide synthase, which is converted to citrulline and nitric oxide (NO). Induces insulin release by a nitric oxide-dependent mechanism.

InChI:InChI=1/C6H14N4O2.C4H7NO4/c7-4(5(11)12)2-1-3-10-6(8)9;5-2(4(8)9)1-3(6)7/h4H,1-3,7H2,(H,11,12)(H4,8,9,10);2H,1,5H2,(H,6,7)(H,8,9)/t4-;2-/m00/s1

7675-83-4 Relevant articles

Inhibition of platelet function by L-arginine. L-aspartate salt

Wang YY 1 , Wang JY , Fu YL , Wang C , Peng SQ

Sheng li xue bao : [Acta Physiologica Sinica], 01 Aug 2001, 53(4):303-306

The effects of L-arginine.L-aspartate salt (DR) on platelet aggregation, adhesion and release were investigated. It is suggested that DR may probably be used as a new agent for regulating platelet function.

Polyaspartoyl· L-arginine inhibits platelet aggregation through stimulation of NO release from endothelial cells

Z Tang, M Zhao, C Li, Y Wang, S Peng

European journal of pharmacology, 2008

The cells of each set were all treated with vehicle, l-arginine, l-aspartate, l-arginine plus l-aspartate or PDR for 30 min at 37 C respectively, accompanied by A23187 (final concentration …

7675-83-4 Process route

: 7675-83-4,23284-30-2
L-aspartic acid, compound with L-arginine (1:1)

Conditions

Conditions	Yield

Benzyliden-arginin, Aspartic-Saeure;

;

Home

About us

Products

API

Others

Biochemical Engineering

Pharmaceutical intermediates

R&D

News

Contact

7675-83-4

Quick Details

Health Care Raw Materials Food Additive L-Arginine-L-aspartate 7675-83-4

L-Arginine L-aspartate(Cas 7675-83-4) Usage

7675-83-4 Relevant articles

Inhibition of platelet function by L-arginine. L-aspartate salt

Wang YY 1 , Wang JY , Fu YL , Wang C , Peng SQ

Sheng li xue bao : [Acta Physiologica Sinica], 01 Aug 2001, 53(4):303-306

Polyaspartoyl· L-arginine inhibits platelet aggregation through stimulation of NO release from endothelial cells

Z Tang, M Zhao, C Li, Y Wang, S Peng

European journal of pharmacology, 2008

7675-83-4 Process route

Relevant Products

Contact Now

Contact us

Maps

links